|
|
.
See Category: Endocrine, nutritional and metabolic diseases
See Header: Type 2 diab w severe nonprlf diabetic rtnop w macular edema
ICD-10 (CM) Code and Descriptor
|
E11.3413 |
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral
|
E113413 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 61.72%
|
14.23%
|
7.55%
|
4.56%
|
2.86%
|
1.96%
|
1.59%
|
1.47%
|
0.92%
|
0.74%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for E11.3413*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
92134
|
CPTRZ OPH DX IMG PST SGM RTA |
2,447
|
2,447
|
|
67028
|
INJECTION EYE DRUG |
2,259
|
2,259
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,267
|
1,270
|
|
J0178
|
AFLIBERCEPT INJECTION |
1,225
|
3,449
|
|
C9257
|
BEVACIZUMAB INJECTION |
831
|
5,564
|
|
92014
|
COMPRE OPH EXAM EST PT 1/> |
475
|
475
|
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
241
|
241
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
206
|
207
|
|
92235
|
FLUORESCEIN ANGRPH MLTIFRAME |
151
|
151
|
|
92012
|
INTRM OPH EXAM EST PATIENT |
143
|
143
|
|
92250
|
FUNDUS PHOTOGRAPHY W/I&R |
140
|
140
|
|
G0467
|
FQHC VISIT, ESTAB PT |
138
|
138
|
|
80053
|
COMPREHEN METABOLIC PANEL |
127
|
127
|
|
J2778
|
RANIBIZUMAB INJECTION |
121
|
513
|
|
80061
|
LIPID PANEL |
102
|
102
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
99
|
99
|
|
J7312
|
DEXAMETHASONE INTRA IMPLANT |
80
|
623
|
|
82043
|
UR ALBUMIN QUANTITATIVE |
79
|
79
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
75
|
75
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
69
|
69
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
E11.3413 related to the following DRG Codes:
008
010
019
124-125
|
